Costs of the metabolic syndrome in elderly individuals: Findings from the Cardiovascular Health Study

Diabetes Care

Volumn 30, Issue 10, 2007, Pages 2553-2558

  Curtis, Lesley H ^a,b   Hammill, Bradley G ^a   Bethel, M Angelyn ^b   Anstrom, Kevin J ^a,b   Gottdiener, John S ^c   Schulman, Kevin A ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; METABOLIC SYNDROME X; PATIENT CARE; RISK FACTOR;

AGED; AGED, 80 AND OVER; CHOLESTEROL, HDL; CONTINENTAL POPULATION GROUPS; COST OF ILLNESS; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPERTENSION; INTERVIEWS; MALE; MEDICARE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; OBESITY; PATIENT EDUCATION; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; UNITED STATES;

EID: 35148833035     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0460     Document Type: Article

References (24)

1. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 7:1595-1607, 1988
2. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
3. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486-2497, 2001
4. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome - a new worldwide definition. Lancet 366:1059-1062, 2005
5. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: Third National Health and Nutrition Examination Survey. JAMA 287:356-359, 2002
6. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gonzalez-Sanchez JL, Seclen S, Villena A, Gonzalez-Villalpando C, Williams K, Haffner SM: Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care 29:685-691, 2006
7. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 28:385-390, 2005
8. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW: C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110:380-385, 2004
9. McNeill AM, Katz R, Girman CJ, Rosamond WD, Wagenknecht LE, Barzilay JI, Tracy RP, Savage PJ, Jackson SA: Metabolic syndrome and cardiovascular disease in older people: the Cardiovascular Health Study. J Am Geriatr Soc 54:1317-1324, 2006
10. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28:2289-2304, 2005
11. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL: The effect of age on the association between body-mass index and mortality. N Engl J Med 338:1-7, 1998
12. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O'Leary DH, Psaty B, Rautaharju P, Tracy RP, Weiler PG, for the Cardiovascular Health Study Research Group (CHS): The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1:263-276, 1991
13. Tell GS, Fried LP, Hermanson B, Manolio TA, Newman AB, Borhani NO: Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol 3:358-366, 1993
14. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart conference on scientific issues related to definition. Circulation 109:433-438, 2004
15. Gold MR, Siegel JE: Cost-Effectiveness in Health and Medicine. Oxford, U.K., Oxford University Press, 1996
16. Lin DY, Ying Z: Semiparametric regression analysis of longitudinal data with informative drop-outs. Biostatistics 4:385-398, 2003
17. Liao L, Jollis JG, Anstrom KJ, Whellan DJ, Kitzman DW, Aurigemma GP, Mark DB, Schulman KA, Gottdiener JS: Costs for heart failure with normal vs. reduced ejection fraction. Arch Intern Med 166:112-118, 2006
18. Scuteri A, Najjar SS, Morrell CH, Lakatta EG: The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 28:882-887, 2005
19. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716, 2002
20. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2. Circulation 112:3066-3072, 2005
21. Sturm R: The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff (Millwood) 21:245-253, 2002
22. Finkelstein EA, Fiebelkorn IC, Wang G: National medical spending attributable to overweight and obesity: how much, and who's paying? Health Aff (Millwood) Suppl. Web Exclusives W3-W26, 2003
23. Fitch K, Pyenson B, Iwasaki K: Metabolic syndrome and employer sponsored medial benefits: an actuarial analysis. Value Health 10:S21-S28, 2007
24. Thorpe KE, Howard DH: The rise in spending among Medicare beneficiaries: the role of chronic disease prevalence and changes in treatment intensity. Health Aff (Millwood) Suppl. Web Exclusives W378-W388, 2006